MBC-11

• Description :

  MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC), with potential to treat tumor-induced bone disease (TIBD) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  511.21

• Molecular Formula :

  C11H20N3O14P3

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  332863-86-2